查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1372823

兽医现场诊断市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、动物类型（伴侣动物和牲畜动物）、样本类型、测试类别、最终用户、地区和竞争细分

Veterinary Point of Care Diagnostics Market-Global Industry Size, Share, Trends, Opportunity, & Forecast, 2018-2028 Segmented By Product, Animal Type (Companion & Livestock Animals), Sample Type, Testing Category, End User, Region & Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年兽医护理点诊断市场价值为 15.1 亿美元，预计在预测期内将大幅增长，预计到 2028 年复合年增长率 (CAGR) 为 10.11%。

在多种因素的共同推动下，该市场目前正呈现显着成长。全球宠物饲养量的增加，加上人们对宠物健康意识的增强，导致对快速、便利的诊断解决方案的需求激增。技术进步已经产生了复杂的、用户友好的设备，可以提供快速、准确的结果，满足兽医和宠物主人的喜好。

包括糖尿病和传染病在内的各种兽医疾病的流行强调了及时、准确诊断的重要性，最终改善了动物医疗保健结果。监管支援以及兽医诊所和医院的扩张进一步增强了市场的成长潜力。此外，诊断设备製造商、兽医机构和学术机构之间的伙伴关係和协作也有助于该领域的持续创新。

市场概况
预测期 2024-2028
2022 年市场规模 15.1亿美元
2028 年市场规模 26.7亿美元
2023-2028 年复合年增长率 10.11%
成长最快的细分市场 传染性疾病
最大的市场 北美洲

随着成本效益、远距医疗和远端监控日益受到重视，现场护理诊断在实现即时健康评估方面发挥关键作用。随着竞争推动创新，兽医现场诊断市场已做好持续成长的准备，成为更广泛的兽医医疗保健产业的重要组成部分。

主要市场驱动因素

增加宠物拥有量

宠物饲养的成长趋势是兽医现场诊断市场快速成长的重要动力。全球范围内宠物拥有量的激增，受到多种因素的影响，从多个方面促进了市场的扩张。

兽医疾病的流行

兽医疾病的流行在影响兽医现场诊断市场的成长方面发挥着至关重要的作用。这项因素对诊断工具的需求产生重大影响，并推动兽医诊断领域的创新。

首先，各种兽医疾病（包括动物传染病、慢性病和癌症）日益流行，需要定期监测和及时诊断。随着这些疾病变得越来越常见，兽医和宠物主人都在寻求准确、快速的诊断解决方案，以便在早期阶段检测和管理这些疾病。护理点诊断具有及时检测的优势，可以更快地进行治疗干预，并有可能改善受影响动物的预后。

此外，新的和不断发展的疾病以及可能影响动物和人类的人畜共患疾病的出现强调了有效和高效诊断的重要性。能够快速识别这些疾病的即时检测对于防止其传播并确保动物及其人类照护人员的健康和安全至关重要。当疾病爆发或监测具有公共卫生影响的疾病时，对此类诊断的需求变得特别明显。

此外，宠物慢性疾病（如糖尿病和肾臟疾病）盛行率不断上升，需要定期监测和管理。护理点诊断为宠物主人提供了一种在家中监测动物健康状况的便捷方式，从而减少了频繁去兽医诊所的需要。这不仅提高了宠物的生活质量，也推动了对便携式诊断设备的需求。

此外，随着全球宠物贸易的不断扩大，疾病传播的风险以及旅行动物健康证明的需求变得越来越重要。现场诊断是在国际旅行或贸易之前验证动物健康状况的重要工具，使其成为促进动物全球流动不可或缺的工具。

主要市场挑战

成本障碍

兽医现场诊断市场面临的主要挑战之一是成本障碍问题。虽然即时诊断设备在便利性和快速结果方面具有众多优势，但其开发、製造和维护成本可能带来重大挑战。

製造现场诊断设备通常需要使用先进技术和专用材料，导致生产成本更高。此外，确保这些设备的准确性和可靠性需要严格的品质控制流程，这可能会进一步增加製造费用。对于财力有限的小型兽医诊所和诊所来说，这些成本可能特别沉重，可能会限制他们采用和使用这些先进诊断工具的能力。

维护成本对于护理点诊断的整体承受能力也起着至关重要的作用。为了保持这些设备的最佳运作状态，需要定期校准、维修和更新。维护费用会随着时间的推移而累积，并可能阻碍兽医诊所投资于即时护理技术，特别是如果他们缺乏支持持续维护的预算或基础设施。

成本障碍的挑战也延伸到了宠物主人。一些即时诊断测试可能需要专门的耗材或试剂，这可能很昂贵。如果宠物主人承担这些费用，定期检测的负担能力可能会成为一个问题，可能会限制诊断频率并影响宠物的整体健康管理。

诊断准确度

确保兽医现场护理诊断的准确性是一项严峻的挑战。虽然这些设备具有快速获得结果和现场测试的优势，但保持一致的高准确度可能很复杂。样品品质变化、操作员错误和设备校准等因素会影响结果的可靠性。

主要问题之一是可能出现假阳性或假阴性，这可能对患者护理产生重大影响。误诊可能会导致不必要的治疗、增加医疗费用以及对宠物主人造成过度的压力。相反，未能发现疾病或状况可能会延迟必要的干预措施，可能导致动物的健康状况恶化。

此外，护理点诊断设备可能并不总是提供与实验室测试相同水平的准确性，而实验室测试通常被认为是黄金标准。这可能会对结果的信心造成挑战，并且可能需要通过额外的测试进行确认，这可能既耗时又昂贵。

主要市场趋势

远距医疗和远端监控的兴起

远距医疗和远端监控的兴起是重塑兽医现场诊断格局的重要趋势。通讯技术的进步以及兽医和宠物主人不断变化的偏好加速了这一趋势。

兽医护理中的远距医疗涉及兽医和宠物主人透过视讯通话或讯息平台进行远端咨询。另一方面，远端监控使兽医能够追踪动物的健康状况并从穿戴式装置和家用诊断套件接收即时资料。护理点诊断在实现远端监控方面发挥关键作用，因为它们使宠物主人能够收集并与兽医共享重要的健康资料，而无需经常亲自拜访。

这种趋势有几个优点。首先，它提高了兽医护理的可及性，特别是在偏远地区或紧急情况下，当立即进入兽医诊所可能具有挑战性时。它还可以减轻动物在就诊时可能感到焦虑的压力。

此外，COVID-19 大流行进一步加速了远距医疗和远端监控在兽医护理中的采用，因为它需要采取物理疏远措施。这场危机凸显了护理点诊断在远端提供基本健康资料、确保护理连续性、同时最大限度地减少人际接触方面的潜力。

护理点诊断与远距医疗和远端监控平台的整合可以即时评估动物的健康状况，促进早期疾病检测和及时干预。它使宠物主人能够积极参与宠物的医疗保健，并为兽医提供更全面的动物健康状况视图。

人工智慧与数据分析的整合

人工智慧 (AI) 和资料分析的整合是兽医现场诊断市场的变革趋势。它代表了诊断设备功能及其为兽医和宠物主人提供可行见解的能力的飞跃。

人工智慧驱动的演算法被用来快速分析即时诊断测试所产生的复杂资料。这项技术可以识别对人类解释可能具有挑战性的微妙模式和趋势。例如，在基于影像的诊断中，人工智慧可以检测放射线影像中的异常情况或高度准确地识别显微玻片中的特定细胞。

数据分析与人工智慧结合，可以开发预测模型。这些模型可以根据历史资料、遗传因素和诊断测试的即时输入来预测健康问题。这样可以采取早期干预和预防措施，显着提高动物照护品质。

人工智慧和资料分析在兽医诊断中的一项突出应用是血液检测结果的解释。演算法可以快速分析全面的血液检测，考虑器官功能、电解质平衡和血球计数等多个参数。这可以对动物的健康状况进行更精确和全面的评估。

此外，人工智慧驱动的诊断设备可以适应并从与患者和医疗保健提供者的互动中学习，随着时间的推移不断提高其诊断准确性。他们可以提供考虑个别动物特定需求的诊断建议，从而有助于兽医护理中的个人化医疗。

细分市场洞察

产品洞察

消耗品、试剂和套件在兽医护理点诊断市场中占据主导地位，预计在未来几年将继续扩大。这些组件是诊断设备操作不可或缺的一部分，其重要性在于其消耗品性质和经常性需求。首先，消耗品、试剂和试剂盒对于在兽医实践中进行各种诊断测试至关重要。无论是血液检测、尿液分析或分子诊断，这些成分都是与样本相互作用产生结果的核心要素。兽医专业人员每天依靠这些消耗品来做出有关动物健康的明智决定。其次，消耗品的重复性推动了持续的需求。兽医诊所和实验室需要稳定的试剂和试剂盒供应，以满足患者的诊断需求。因此，消耗品占兽医机构持续营运支出的很大一部分，确保了製造商和供应商的可靠市场。

第三，诊断技术的进步通常涉及新的和改进的消耗品、试剂和试剂盒的开发。製造商不断创新，以提高这些组件的准确性、特异性和易用性，从而透过产品开发推动市场成长。

此外，远端和行动兽医服务中采用现场诊断增加了对便携式、方便的套件和耗材的需求，这些套件和耗材可以轻鬆运输并在不同环境中使用。

区域洞察

到2022年，北美地区已成为兽医现场诊断市场的领导者。首先，北美拥有强大且发达的兽医医疗保健基础设施。该地区拥有大量兽医诊所、医院和研究机构，处于采用先进诊断技术的最前线。这个广泛的医疗保健提供者网路为 VPOC 诊断设备和相关耗材创造了强大的需求基础。其次，该地区高度重视宠物饲养和动物健康。尤其是美国和加拿大，多年来宠物拥有量大幅增加，导致人们对宠物医疗保健需求的认识不断提高。北美的宠物主人更倾向于投资尖端诊断工具和服务，为 VPOC 市场的成长做出贡献。此外，北美是兽医领域的创新和研究中心。 VPOC 市场的领先公司以及学术机构正在积极致力于研发工作，以创建先进的诊断解决方案。这种创新文化推动了新技术的快速采用并推动了市场成长。此外，北美有利的监管框架和严格的品质标准激发了人们对 VPOC 诊断产品的信心。这些法规确保了诊断设备的安全性、准确性和可靠性，培养了兽医专业人员和宠物主人之间的信任。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球兽医护理点诊断市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（消耗品、试剂和套件与仪器和设备）
    • 依动物类型{伴侣动物（狗、猫、马、其他）、牲畜（牛、猪、家禽、其他）
    • 依样本类型（血液/血浆/血清、尿液、粪便、其他）
    • 依适应症（传染病、一般疾病、其他）
    • 按测试类别（血液学、诊断影像学、细菌学、病毒学、细胞学、临床化学、寄生虫学、血清学、其他）
    • 按最终使用者（兽医医院和诊所、家庭护理机构、其他）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美兽医护理点诊断市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依样品类型
    • 按指示
    • 按测试类别
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲兽医护理点诊断市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依样品类型
    • 按指示
    • 按测试类别
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区兽医现场诊断市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依样品类型
    • 按指示
    • 按测试类别
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲兽医护理点诊断市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依样品类型
    • 按指示
    • 按测试类别
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲兽医护理点诊断市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依样品类型
    • 按指示
    • 按测试类别
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非兽医护理点诊断
    • 沙乌地阿拉伯兽医护理点诊断
    • 阿联酋兽医护理点诊断

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购

第 13 章：全球兽医护理点诊断市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代治疗类型的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Zoetis Inc.
    • IDEXX Laboratories, Inc.
    • Virbac SA
    • Heska Corporation
    • Thermo Fisher Scientific, Inc
    • Mindray Medical International Limited
    • Esaote SPA
    • FUJIFILM Corporation
    • Woodley Equipment Company Ltd

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 16301

The Veterinary Point of Care Diagnostics Market, valued at USD 1.51 Billion in 2022, is expected to undergo substantial growth in the forecast period, with an anticipated Compound Annual Growth Rate (CAGR) of 10.11% through 2028.

This market is currently witnessing remarkable growth, driven by a convergence of various factors. The global rise in pet ownership, combined with an increased awareness of pet health, has led to a surge in demand for rapid and convenient diagnostic solutions. Technological advancements have yielded sophisticated, user-friendly devices that provide quick and accurate results, catering to the preferences of both veterinarians and pet owners.

The prevalence of various veterinary diseases, including diabetes and infectious ailments, emphasizes the importance of timely and precise diagnoses, ultimately improving animal healthcare outcomes. Regulatory support and the expansion of veterinary clinics and hospitals further reinforce the market's growth potential. Additionally, partnerships and collaborations among diagnostic device manufacturers, veterinary facilities, and academic institutions contribute to ongoing innovation in this sector.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.51 Billion
Market Size 2028USD 2.67 Billion
CAGR 2023-202810.11%
Fastest Growing SegmentInfectious Diseases
Largest MarketNorth America

As cost-efficiency, telemedicine, and remote monitoring gain prominence, point-of-care diagnostics assume a pivotal role in enabling real-time health assessments. With competition driving innovation, the veterinary point-of-care diagnostics market is well-positioned for sustained growth, establishing itself as a crucial component of the broader veterinary healthcare industry.

Key Market Drivers

Increasing Pet Ownership

The increasing trend of pet ownership is a significant driving force behind the rapid growth of the veterinary point-of-care diagnostics market. This surge in pet ownership is seen across the globe and is influenced by various factors, contributing to the expansion of the market in several ways.

Firstly, the growing number of pet owners translates into a larger patient base for veterinarians. As more people open their homes to companion animals, the demand for veterinary services, including diagnostics, naturally rises. This trend is not limited to traditional pets like dogs and cats but extends to exotic pets as well, widening the market's scope.

Secondly, pet owners are increasingly viewing their pets as cherished family members, leading to a heightened awareness of the importance of maintaining their health and well-being. As a result, pet owners are more willing to invest in veterinary care, including diagnostic tests, to ensure their pets lead healthy lives. This mindset shift has created a substantial demand for point-of-care diagnostics that offer quick and accurate results, allowing for timely interventions and personalized treatment plans.

Thirdly, the emotional attachment between pet owners and their animals has led to a willingness to go the extra mile for their pets' healthcare needs. This includes regular check-ups and preventive measures, often involving point-of-care diagnostics for early disease detection. Pet owners are now more proactive in seeking out healthcare services for their pets, driving up the demand for veterinary diagnostic tools.

Additionally, the rise in pet ownership has led to an increased need for diagnostics in various settings beyond traditional veterinary clinics. Pet owners are seeking diagnostic tools that they can use at home to monitor their pets' health, especially for chronic conditions like diabetes. This has spurred innovation in the development of user-friendly, portable, and accurate point-of-care diagnostic devices that cater to both veterinary professionals and pet owners.

Prevalence of Veterinary Diseases

The prevalence of veterinary diseases plays a vital role in influencing the growth of the veterinary point-of-care diagnostics market. This factor has a significant impact on the demand for diagnostic tools and drives innovation in the field of veterinary diagnostics.

First and foremost, the increasing prevalence of various veterinary diseases, including infectious diseases, chronic conditions, and cancer among animals, necessitates regular monitoring and prompt diagnosis. As these diseases become more common, veterinarians and pet owners alike seek accurate and rapid diagnostic solutions to detect and manage these conditions at an early stage. Point-of-care diagnostics offer the advantage of timely detection, enabling quicker treatment interventions and potentially improving the prognosis for affected animals.

Moreover, the emergence of new and evolving diseases, as well as zoonotic diseases that can affect both animals and humans, underscores the importance of effective and efficient diagnostics. Point-of-care tests that can quickly identify these diseases are critical for preventing their spread and ensuring the health and safety of both animals and their human caregivers. The need for such diagnostics becomes particularly evident in cases of disease outbreaks or when monitoring diseases with public health implications.

Additionally, the rising prevalence of chronic diseases in pets, such as diabetes and kidney disease, necessitates regular monitoring and management. Point-of-care diagnostics provide a convenient way for pet owners to monitor their animals' health at home, reducing the need for frequent visits to veterinary clinics. This not only improves the quality of life for pets but also drives demand for portable diagnostic devices.

Furthermore, as the global pet trade continues to expand, the risk of disease transmission and the need for health certificates for traveling animals have become increasingly important. Point-of-care diagnostics are essential tools in verifying the health status of animals before international travel or trade, making them indispensable in facilitating global movements of animals.

Key Market Challenges

Cost Barriers

One of the key challenges facing the veterinary point-of-care diagnostics market is the issue of cost barriers. While point-of-care diagnostic devices offer numerous advantages in terms of convenience and rapid results, their development, manufacturing, and maintenance costs can pose significant challenges.

Manufacturing point-of-care diagnostic devices often involves the use of advanced technology and specialized materials, contributing to higher production costs. Additionally, ensuring the accuracy and reliability of these devices requires rigorous quality control processes, which can further increase manufacturing expenses. These costs can be especially burdensome for smaller veterinary practices and clinics with limited financial resources, potentially limiting their ability to adopt and use these advanced diagnostic tools.

Maintenance costs also play a crucial role in the overall affordability of point-of-care diagnostics. Regular calibration, servicing, and updates are necessary to keep these devices functioning optimally. Maintenance expenses can accumulate over time and may deter veterinary practices from investing in point-of-care technology, especially if they lack the budget or infrastructure to support ongoing maintenance.

The cost barrier challenge extends to pet owners as well. Some point-of-care diagnostic tests may require specialized consumables or reagents, which can be expensive. In cases where pet owners are responsible for these costs, the affordability of regular testing may become a concern, potentially limiting the frequency of diagnostics and affecting the overall health management of their pets.

Diagnostic Accuracy

Ensuring the accuracy of point-of-care diagnostics in veterinary medicine is a critical challenge. While these devices offer the advantage of rapid results and on-site testing, maintaining consistently high levels of accuracy can be complex. Factors such as variations in sample quality, operator error, and device calibration can influence the reliability of results.

One of the primary concerns is the potential for false positives or false negatives, which can have significant consequences for patient care. Misdiagnoses can lead to unnecessary treatments, increased healthcare costs, and undue stress for pet owners. Conversely, failing to detect a disease or condition can delay necessary interventions, potentially leading to worsened health outcomes for animals.

Additionally, point-of-care diagnostic devices may not always provide the same level of accuracy as laboratory-based tests, which are often considered the gold standard. This can create challenges in terms of confidence in the results and may necessitate confirmation through additional testing, which can be time-consuming and costly.

Key Market Trends

Rise in Telemedicine and Remote Monitoring

The rise of telemedicine and remote monitoring is a significant trend reshaping the landscape of veterinary point-of-care diagnostics. This trend has been accelerated by advancements in communication technology and the changing preferences of both veterinarians and pet owners.

Telemedicine in veterinary care involves the remote consultation between veterinarians and pet owners through video calls or messaging platforms. Remote monitoring, on the other hand, enables veterinarians to track an animal's health status and receive real-time data from wearable devices and at-home diagnostic kits. Point-of-care diagnostics play a pivotal role in enabling remote monitoring, as they empower pet owners to collect and share vital health data with veterinarians without the need for frequent in-person visits.

This trend offers several advantages. First, it enhances accessibility to veterinary care, particularly in remote areas or during emergencies when immediate access to a veterinary clinic may be challenging. It also reduces stress for animals that may be anxious during visits to a clinic.

Furthermore, the COVID-19 pandemic further accelerated the adoption of telemedicine and remote monitoring in veterinary care as it necessitated physical distancing measures. This crisis highlighted the potential of point-of-care diagnostics to provide essential health data remotely, ensuring continuity of care while minimizing human contact.

The integration of point-of-care diagnostics with telemedicine and remote monitoring platforms allows for real-time assessment of an animal's health, facilitating early disease detection and timely interventions. It empowers pet owners to actively participate in their pets' healthcare and provides veterinarians with a more comprehensive view of an animal's health over time.

Integration of AI and Data Analytics

The integration of artificial intelligence (AI) and data analytics is a transformative trend in the veterinary point-of-care diagnostics market. It represents a leap forward in the capabilities of diagnostic devices and their ability to provide actionable insights for veterinarians and pet owners.

AI-driven algorithms are being employed to analyze complex data generated by point-of-care diagnostic tests rapidly. This technology can identify subtle patterns and trends that may be challenging for human interpretation. For example, in image-based diagnostics, AI can detect abnormalities in radiographic images or identify specific cells in microscopic slides with a high degree of accuracy.

Data analytics, coupled with AI, enables the development of predictive models. These models can anticipate health issues based on historical data, genetic factors, and real-time inputs from diagnostic tests. This allows for early intervention and preventive measures, significantly improving the quality of care for animals.

One prominent application of AI and data analytics in veterinary diagnostics is in the interpretation of blood test results. Algorithms can quickly analyze comprehensive blood panels, considering multiple parameters such as organ function, electrolyte balance, and blood cell counts. This results in more precise and holistic assessments of an animal's health status.

Moreover, AI-driven diagnostic devices can adapt and learn from their interactions with patients and healthcare providers, continuously improving their diagnostic accuracy over time. They can provide diagnostic recommendations that consider the specific needs of an individual animal, thereby contributing to personalized medicine in veterinary care.

Segmental Insights

Product Insights

The Consumables, Reagents, & Kits dominate the Veterinary Point of Care Diagnostics market and is predicted to continue expanding over the coming years. These components are integral to the operation of diagnostic devices, and their significance lies in their consumable nature and recurring need. Firstly, consumables, reagents, and kits are essential for performing a wide range of diagnostic tests in veterinary practice. Whether it's blood tests, urine analysis, or molecular diagnostics, these components serve as the core elements that interact with samples to produce results. Veterinary professionals rely on these consumables daily to make informed decisions about animal health. Secondly, the recurring nature of consumables drives consistent demand. Veterinary clinics and laboratories require a steady supply of reagents and kits to meet the diagnostic needs of their patients. As a result, consumables form a substantial portion of the ongoing operational expenses for veterinary facilities, ensuring a reliable market for manufacturers and suppliers.

Thirdly, advancements in diagnostic technologies often involve the development of new and improved consumables, reagents, and kits. Manufacturers are continually innovating to enhance the accuracy, specificity, and ease of use of these components, thereby driving market growth through product development.

Moreover, the adoption of point-of-care diagnostics in remote and mobile veterinary services has boosted the demand for portable and convenient kits and consumables that can be easily transported and used in diverse settings.

Regional Insights

The North America region has established itself as the leader in the Veterinary Point of Care Diagnostics Market in 2022. Firstly, North America boasts a robust and well-developed veterinary healthcare infrastructure. The region is home to a large number of veterinary clinics, hospitals, and research institutions that are at the forefront of adopting advanced diagnostic technologies. This extensive network of healthcare providers creates a strong demand base for VPOC diagnostic devices and associated consumables. Secondly, the region places a high premium on pet ownership and animal health. The United States and Canada, in particular, have witnessed a substantial increase in pet ownership over the years, resulting in heightened awareness of pet healthcare needs. Pet owners in North America are more inclined to invest in cutting-edge diagnostic tools and services, contributing to the growth of the VPOC market. Additionally, North America is a hub of innovation and research in the field of veterinary medicine. Leading companies in the VPOC market, as well as academic institutions, are actively engaged in research and development efforts to create advanced diagnostic solutions. This innovation culture drives the rapid adoption of new technologies and fuels market growth. Furthermore, favorable regulatory frameworks and stringent quality standards in North America inspire confidence in VPOC diagnostic products. These regulations ensure the safety, accuracy, and reliability of diagnostic devices, fostering trust among veterinary professionals and pet owners.

Key Market Players

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Virbac SA
  • Heska Corporation
  • Thermo Fisher Scientific, Inc
  • Mindray Medical International Limited
  • Esaote S.P.A.
  • FUJIFILM Corporation
  • Woodley Equipment Company Ltd

Report Scope:

In this report, the Veterinary Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Point of Care Diagnostics Market, Product:

  • Short PIVCs
  • Huber Needles
  • Midline Catheters
  • PICCs
  • CVCs
  • Dialysis Catheters
  • Implantable Ports

Veterinary Point of Care Diagnostics Market, Animal Type:

  • Companion Animals
  • Livestock Animals

Veterinary Point of Care Diagnostics Market, Sample Type:

  • Blood/Plasma/Serum
  • Urine
  • Fecal
  • Others

Veterinary Point of Care Diagnostics Market, Indication:

  • Infectious Disease
  • General Ailments
  • Others

Veterinary Point of Care Diagnostics Market, Testing Category:

  • Hematology
  • Diagnostic Imaging
  • Bacteriology
  • Virology
  • Cytology
  • Clinical Chemistry
  • Parasitology
  • Serology
  • Others

Veterinary Point of Care Diagnostics Market, End User:

  • Veterinary Hospitals & Clinics
  • Home Care Settings
  • Others

Veterinary Point of Care Diagnostics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Veterinary Point of Care Diagnostics Market.

Available Customizations:

  • Veterinary Point of Care Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Point of Care Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Reagents, & Kits v/s Instruments & Devices)
    • 5.2.2. By Animal Type {Companion Animals (Dogs, Cats, Horses, Others), Livestock Animals (Cattle, Swine, Poultry, Others)
    • 5.2.3. By Sample Type (Blood/Plasma/Serum, Urine, Fecal, Others)
    • 5.2.4. By Indication (Infectious Disease, General Ailments, Others)
    • 5.2.5. By Testing Category (Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others)
    • 5.2.6. By End User (Veterinary Hospitals & Clinics, Home Care Settings, Others)
    • 5.2.7. By Region
    • 5.2.8. By Company (2022)
  • 5.3. Market Map

6. North America Veterinary Point of Care Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Animal Type
    • 6.2.3. By Sample Type
    • 6.2.4. By Indication
    • 6.2.5. By Testing Category
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Point of Care Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Animal Type
        • 6.3.1.2.3. By Sample Type
        • 6.3.1.2.4. By Indication
        • 6.3.1.2.5. By Testing Category
        • 6.3.1.2.6. By End User
    • 6.3.2. Canada Veterinary Point of Care Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Animal Type
        • 6.3.2.2.3. By Sample Type
        • 6.3.2.2.4. By Indication
        • 6.3.2.2.5. By Testing Category
        • 6.3.2.2.6. By End User
    • 6.3.3. Mexico Veterinary Point of Care Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Animal Type
        • 6.3.3.2.3. By Sample Type
        • 6.3.3.2.4. By Indication
        • 6.3.3.2.5. By Testing Category
        • 6.3.3.2.6. By End User

7. Europe Veterinary Point of Care Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Animal Type
    • 7.2.3. By Sample Type
    • 7.2.4. By Indication
    • 7.2.5. By Testing Category
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By Sample Type
        • 7.3.1.2.4. By Indication
        • 7.3.1.2.5. By Testing Category
        • 7.3.1.2.6. By End User
    • 7.3.2. United Kingdom Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By Sample Type
        • 7.3.2.2.4. By Indication
        • 7.3.2.2.5. By Testing Category
        • 7.3.2.2.6. By End User
    • 7.3.3. Italy Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By Sample Type
        • 7.3.3.2.4. By Indication
        • 7.3.3.2.5. By Testing Category
        • 7.3.3.2.6. By End User
    • 7.3.4. France Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Animal Type
        • 7.3.4.2.3. By Sample Type
        • 7.3.4.2.4. By Indication
        • 7.3.4.2.5. By Testing Category
        • 7.3.4.2.6. By End User
    • 7.3.5. Spain Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Animal Type
        • 7.3.5.2.3. By Sample Type
        • 7.3.5.2.4. By Indication
        • 7.3.5.2.5. By Testing Category
        • 7.3.5.2.6. By End User

8. Asia-Pacific Veterinary Point of Care Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Animal Type
    • 8.2.3. By Sample Type
    • 8.2.4. By Indication
    • 8.2.5. By Testing Category
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By Sample Type
        • 8.3.1.2.4. By Indication
        • 8.3.1.2.5. By Testing Category
        • 8.3.1.2.6. By End User
    • 8.3.2. India Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By Sample Type
        • 8.3.2.2.4. By Indication
        • 8.3.2.2.5. By Testing Category
        • 8.3.2.2.6. By End User
    • 8.3.3. Japan Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Sample Type
        • 8.3.3.2.4. By Indication
        • 8.3.3.2.5. By Testing Category
        • 8.3.3.2.6. By End User
    • 8.3.4. South Korea Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Animal Type
        • 8.3.4.2.3. By Sample Type
        • 8.3.4.2.4. By Indication
        • 8.3.4.2.5. By Testing Category
        • 8.3.4.2.6. By End User
    • 8.3.5. Australia Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Animal Type
        • 8.3.5.2.3. By Sample Type
        • 8.3.5.2.4. By Indication
        • 8.3.5.2.5. By Testing Category
        • 8.3.5.2.6. By End User

9. South America Veterinary Point of Care Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Animal Type
    • 9.2.3. By Sample Type
    • 9.2.4. By Indication
    • 9.2.5. By Testing Category
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Point of Care Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By Sample Type
        • 9.3.1.2.4. By Indication
        • 9.3.1.2.5. By Testing Category
        • 9.3.1.2.6. By End User
    • 9.3.2. Argentina Veterinary Point of Care Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By Sample Type
        • 9.3.2.2.4. By Indication
        • 9.3.2.2.5. By Testing Category
        • 9.3.2.2.6. By End User
    • 9.3.3. Colombia Veterinary Point of Care Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By Sample Type
        • 9.3.3.2.4. By Indication
        • 9.3.3.2.5. By Testing Category
        • 9.3.3.2.6. By End User

10. Middle East and Africa Veterinary Point of Care Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Animal Type
    • 10.2.3. By Sample Type
    • 10.2.4. By Indication
    • 10.2.5. By Testing Category
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Point of Care Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By Sample Type
        • 10.3.1.2.4. By Indication
        • 10.3.1.2.5. By Testing Category
        • 10.3.1.2.6. By End User
    • 10.3.2. Saudi Arabia Veterinary Point of Care Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By Sample Type
        • 10.3.2.2.4. By Indication
        • 10.3.2.2.5. By Testing Category
        • 10.3.2.2.6. By End User
    • 10.3.3. UAE Veterinary Point of Care Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By Sample Type
        • 10.3.3.2.4. By Indication
        • 10.3.3.2.5. By Testing Category
        • 10.3.3.2.6. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions

13. Global Veterinary Point of Care Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Zoetis Inc.
    • 15.5.2. IDEXX Laboratories, Inc.
    • 15.5.3. Virbac SA
    • 15.5.4. Heska Corporation
    • 15.5.5. Thermo Fisher Scientific, Inc
    • 15.5.6. Mindray Medical International Limited
    • 15.5.7. Esaote S.P.A.
    • 15.5.8. FUJIFILM Corporation
    • 15.5.9. Woodley Equipment Company Ltd

16. Strategic Recommendations

17. About Us & Disclaimer